Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.30
-0.08 (-1.49%)
At close: Dec 30, 2025, 4:00 PM EST
5.19
-0.11 (-2.08%)
After-hours: Dec 30, 2025, 6:31 PM EST
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $10.17 million as of December 30, 2025. Its market cap has decreased by -52.24% in one year.
Market Cap
10.17M
Enterprise Value
1.85M
1-Year Change
-52.24%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $10.17M, a decrease of -98.53%. That is a compound annual growth rate of -57.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 10.33M | -49.58% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.74B |
| Johnson & Johnson | 498.94B |
| AbbVie | 405.28B |
| UnitedHealth Group | 302.22B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.29B |
| Novo Nordisk | 229.27B |